MedDataX Logo

Sleep Disturbances and Pulmonary Artery/Aorta Diameter in Scleroderma Patient

NCT ID: NCT00566137

Last Updated: 2010-03-09

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-02-28

Study Completion Date

2007-02-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To determine sleep disturbance, pulmonary function test, 6 minute walk, echocardiogram abnormality, arterial blood gas, ventilation/perfusion scan of the chest in Scleroderma patient with Pulmonary Hypertension.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

SCOR in Neurobiology of Sleep--Intermediate Traits for Sleep Apnea

NCT00005511

Lung Diseases Sleep Apnea Syndromes
COMPLETED

Evaluation of the Noga System: Detecting of Respiratory Related Sleep Disorders in Cardiac Patients

NCT00800397

Sleep Apnea
COMPLETED

Heart Function in Patients Assessed for Sleep Apnoea

NCT03226652

Heart Failure With Preserved Ejection Fraction Sleep Disordered Breathing Heart Failure With Normal Ejection Fraction +3 more
COMPLETED

Age-related Prevalence of Sleep Respiratory Disturbances

NCT00005297

Lung Diseases Heart Diseases Hypertension +1 more
COMPLETED

Sleep Apnea in a Non-Clinical Population

NCT00005551

Lung Diseases Sleep Apnea Syndromes Obesity +3 more
COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

As above

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Scleroderma Pulmonary Hypertension

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient must have Scleroderma

Exclusion Criteria

* Patients who do not have Scleroderma
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Northwell Health

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

NORTH SHORE- LONG ISLAND HEALTH SYSTEM

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Arunabh Talwar, MD

Role: PRINCIPAL_INVESTIGATOR

Northwell Health

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

NS-LIJHS IRB #06-08-018

Identifier Type: -

Identifier Source: secondary_id

06-08-018

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Nocturnal Oxygenation and Sleep-related Breathing Disorders During the First Night of a Stay at 2500m of High Altitude in Patients With Precapillary Pulmonary Hypertension
NCT05089487 COMPLETED NA
The Prevalence and Risk Factors of Sleep Disordered Breathing in a Heart Failure Program
NCT00679822 COMPLETED
Prevalence of Sleep Disordered Breathing in a Lung Cancer Screening Cohort
NCT02687997 COMPLETED NA
Influence of Sleep Apnea on Risk of Atrial Fibrillation
NCT02576587 COMPLETED NA
Prevalence, Phenotypes, Predictors and Prognostic Implication of Obstructive Sleep Apnea in Pulmonary Hypertension
NCT05595200 RECRUITING
PRedictOrs, PHEnotypes and Timing of Obstructive Sleep Apnea in Acute Coronary Syndrome
NCT04002739 UNKNOWN NA
Screening for Sleep Hypoxemia in Pulmonary Arterial Hypertension
NCT01371669 COMPLETED
Evaluating the Relationship Between Sleep-Disordered Breathing and Daytime Alertness
NCT00393913 COMPLETED
The Severity Of Individual Breathing Cessation Events In Diagnostics Of Obstructive Sleep Apnea
NCT03232658 UNKNOWN
Peripheral Vascular Function in Obstructive Sleep Apnoea
NCT01619748 COMPLETED
Mechanisms for Atrial Fibrillation in Obstructive Sleep Apnea
NCT06465134 RECRUITING
Hemodynamics Response to Upper Airway Obstruction in Marfan Syndrome
NCT03985657 COMPLETED NA
Prevalence of Sleep Disordered Breathing
NCT01011647 TERMINATED
The Meaning of Dopaminergic Pathway in Sleep Breathing Disorders.
NCT05890911 ENROLLING_BY_INVITATION
Validation of the "ApneaScan" Algorithm for the Detection of Sleep Disordered Breathing in Chronic Heart Failure
NCT01979120 UNKNOWN
Exploring the Patterns of Sleep Disordered Breathing in Systemic Sclerosis Patients
NCT07175246 NOT_YET_RECRUITING
Actigraphy Sleep Parameters in Obstructive Sleep Apnea Patient's
NCT03060915 COMPLETED NA
Validation of Ambulatory Sleep Test (WP200/U) Compared In-lab Sleep Testing in Cardiac Subjects
NCT02369705 COMPLETED
Echocardiographic Assessment of Pulmonary Hypertension in Obstructive Sleep Apnea
NCT07184060 NOT_YET_RECRUITING
Sleep Apnea Screening
NCT02569749 TERMINATED
The Epidemiology of Sleep Disordered Breathing in Patients With Congestive Heart Failure
NCT05332223 COMPLETED
Regulation of Pharyngeal Muscle Contraction - SCOR in Cardiopulmonary Disorders of Sleep
NCT00005320 COMPLETED
The Prevalence of Sleep Disordered Breathing in Hospitalized Patients With Acutely Decompensated Heart Failure Syndrome
NCT00701519 COMPLETED
Mass Spectral Fingerprinting in Obstructive Sleep Apnoea
NCT02810158 COMPLETED
Accelerated Aging in Middle-Aged Men With Sleep-disordered Breathing.
NCT02876653 COMPLETED NA